526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹11
- High
- ₹12
- 52 Week Low
- ₹10
- 52 Week High
- ₹38
- Open Price₹12
- Previous Close₹12
- Volume199,544
Investment Returns
- Over 1 Month -19.35%
- Over 3 Month -5.34%
- Over 6 Month -14.29%
- Over 1 Year -67.21%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -7.1
- PEG Ratio
- 0
- Market Cap Cr
- 54
- P/B Ratio
- 0.7
- Average True Range
- 0.97
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.31
- RSI
- 20.85
- MFI
- 24.05
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹11.88
-0.35
(-2.86%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹13.24
- 50 Day
- ₹13.66
- 100 Day
- ₹14.18
- 200 Day
- ₹17.60
Resistance and Support
11.39
- R3 13.07
- R2 12.54
- R1 11.92
- S1 10.77
- S2 10.24
- S3 9.62
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹11 As on 01 January, 2026 | 04:42
The Market Cap of Indrayani Biotech is ₹54.1 Cr As on 01 January, 2026 | 04:42
The P/E ratio of Indrayani Biotech is -7.1 As on 01 January, 2026 | 04:42
The PB ratio of Indrayani Biotech is 0.7 As on 01 January, 2026 | 04:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.